<DOC>
	<DOCNO>NCT01268917</DOCNO>
	<brief_summary>Antiplatelet therapy critical management coronary artery disease.For patient undergo off-pump coronary artery bypass graft , controversy remain regard safety preoperative antiplatelet therapy.And little study effect continue aspirin surgery day graft patency.So would like perform study evaluate effect preoperative aspirin graft patency cardiac event off-pump coronary bypass .</brief_summary>
	<brief_title>The Effects Preoperative Aspirin Graft Patency Cardiac Events Off-pump Coronary Artery Bypass</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patients undergo elective , offpump coronary artery bypass least two grafts patient able give inform consent onpump CABG combine valve surgery Preoperative use clopidogrel warfarin allergy aspirin History severe liver disease History bleeding diathesis , significant GI bleed Patient know renal failure contraindication Cardiac CT Angio Redo CABG</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>off-pump coronary artery bypass</keyword>
	<keyword>aspirin</keyword>
</DOC>